Unlock Your Share of $100B in Non-Dilutive Capital
Join EGC for this exclusive event to discover how innovative companies can tap into the $100 billion of non-dilutive funding available each year. Gain expert insight from Dr. Eva Garland as she guides you through the complex U.S. funding landscape, covering hundreds of government programs as well as private foundation grants. Plus, hear from Stanley Kim on how WinSanTor secured over $ 20 million in non-dilutive funding to drive cutting-edge advancements.
Agenda
- 3:30 PM – Welcome
Check in and connect with fellow attendees.
- 4:00 PM – Presentation by Dr. Eva Garland with Special Guest, Stanley Kim
Gain expert insights from Dr. Eva Garland as she guides you through integrating non-dilutive funding into a comprehensive financing strategy. Plus, hear from Stanley Kim on how WinSanTor secured over $20 million in non-dilutive funding to drive cutting-edge advancements.
- 5:00 to 7:00 PM – Cocktail Reception
Enjoy drinks and hors d’oeuvres as you mingle with distinguished guests.
Location
The Cove @ UCI Beall Applied Innovation
5270 California Ave., Suite 300, Irvine, CA 92617
In this Seminar:
- Discover Over $100 Billion in Annual Non-Dilutive Funding Opportunities: Gain a comprehensive understanding of the vast landscape of non-dilutive funding available to innovative companies, including programs from the NIH, ARPA-H, BARDA, and DoD.
- Integrate Non-Dilutive Funding into a Comprehensive Financing Strategy: Learn how non-dilutive sources can complement traditional equity-based funding, resulting in a greater probability of success as well as higher ROI and valuations at exit.
- Gain Practical Insights from a Successful Case Study: Hear from WinSanTor CEO Stanley Kim on how WinSanTor secured over $20 million in non-dilutive funding to advance treatments for peripheral neuropathy, providing a real-world example of leveraging non-dilutive sources to move from pre-clinical to clinical development.